KIDS
Income statement / Annual
Last year (2023), OrthoPediatrics Corp.'s total revenue was $148.73 M,
an increase of 21.62% from the previous year.
In 2023, OrthoPediatrics Corp.'s net income was -$20.97 M.
See OrthoPediatrics Corp.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$148.73 M
|
$122.29 M
|
$98.05 M
|
$71.08 M
|
$72.55 M
|
$57.56 M
|
$45.62 M
|
$37.30 M
|
$31.00 M
|
$23.68 M
|
| Cost of Revenue |
$37.48 M |
$31.63 M |
$24.65 M |
$16.05 M |
$17.93 M |
$14.88 M |
$11.17 M |
$10.93 M |
$9.37 M |
$7.09 M |
| Gross Profit |
$111.25 M |
$90.66 M |
$73.40 M |
$55.03 M |
$54.62 M |
$42.68 M |
$34.45 M |
$26.37 M |
$21.64 M |
$16.60 M |
| Gross Profit Ratio |
0.75 |
0.74 |
0.75 |
0.77 |
0.75 |
0.74 |
0.76 |
0.71 |
0.7 |
0.7 |
| Research and Development
Expenses |
$10.20 M
|
$8.01 M
|
$5.54 M
|
$5.27 M
|
$5.75 M
|
$4.73 M
|
$3.42 M
|
$2.22 M
|
$1.79 M
|
$1.68 M
|
| General & Administrative
Expenses |
$75.42 M
|
$59.38 M
|
$46.06 M
|
$38.32 M
|
$26.66 M
|
$20.94 M
|
$16.97 M
|
$13.61 M
|
$11.41 M
|
$9.88 M
|
| Selling & Marketing
Expenses |
$51.40 M
|
$45.05 M
|
$39.67 M
|
$31.85 M
|
$31.28 M
|
$26.56 M
|
$20.53 M
|
$16.66 M
|
$15.03 M
|
$12.19 M
|
| Selling, General &
Administrative Expenses |
$126.82 M
|
$104.44 M
|
$85.73 M
|
$70.17 M
|
$57.95 M
|
$47.50 M
|
$37.50 M
|
$30.27 M
|
$26.44 M
|
$22.06 M
|
| Other Expenses |
$0.00 |
-$1.80 M |
$1.08 M |
$20,000.00 |
-$70,000.00 |
-$217,000.00 |
$30,000.00 |
$1.03 M |
-$31,000.00 |
-$67,000.00 |
| Operating Expenses |
$137.02 M |
$112.45 M |
$91.28 M |
$75.44 M |
$63.70 M |
$52.23 M |
$40.92 M |
$32.49 M |
$28.23 M |
$23.74 M |
| Cost And Expenses |
$174.50 M |
$144.08 M |
$115.92 M |
$91.49 M |
$81.63 M |
$67.11 M |
$52.09 M |
$43.43 M |
$37.60 M |
$30.83 M |
| Interest Income |
$198,000.00 |
$2.42 M |
$2.25 M |
$3.41 M |
$3.54 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$2.42 M |
$2.25 M |
$3.41 M |
$3.54 M |
$2.26 M |
$2.49 M |
$1.48 M |
$1.23 M |
$2.55 M |
| Depreciation &
Amortization |
$17.39 M
|
$13.10 M
|
$10.68 M
|
$7.91 M
|
$4.64 M
|
$2.89 M
|
$2.41 M
|
$1.90 M
|
$1.85 M
|
$1.58 M
|
| EBITDA |
-$8.38 M
|
-$7.93 M
|
-$7.19 M
|
-$22.35 M
|
-$4.51 M
|
-$6.88 M
|
-$4.04 M
|
-$3.19 M
|
-$4.77 M
|
-$5.63 M
|
| EBITDA Ratio |
-0.06 |
-0.09 |
-0.06 |
-0.17 |
-0.06 |
-0.12 |
-0.09 |
-0.09 |
-0.15 |
-0.24 |
| Operating Income Ratio
|
-0.17
|
-0.18
|
-0.18
|
-0.29
|
-0.13
|
-0.17
|
-0.14
|
-0.16
|
-0.21
|
-0.3
|
| Total Other
Income/Expenses Net |
$4.45 M
|
$18.10 M
|
$486,000.00
|
-$6.91 M
|
-$3.61 M
|
-$2.47 M
|
-$2.46 M
|
-$445,000.00
|
-$1.26 M
|
-$2.62 M
|
| Income Before Tax |
-$21.31 M |
-$3.69 M |
-$17.39 M |
-$33.67 M |
-$12.69 M |
-$12.03 M |
-$8.93 M |
-$6.57 M |
-$7.85 M |
-$9.76 M |
| Income Before Tax Ratio
|
-0.14
|
-0.03
|
-0.18
|
-0.47
|
-0.17
|
-0.21
|
-0.2
|
-0.18
|
-0.25
|
-0.41
|
| Income Tax Expense |
-$338,000.00 |
-$4.95 M |
-$1.13 M |
-$723,000.00 |
$4.51 M |
-$217,000.00 |
$2.52 M |
$2.51 M |
$1.24 M |
$2.27 M |
| Net Income |
-$20.97 M |
$1.26 M |
-$16.26 M |
-$32.94 M |
-$17.20 M |
-$12.03 M |
-$8.93 M |
-$6.57 M |
-$7.89 M |
-$9.55 M |
| Net Income Ratio |
-0.14 |
0.01 |
-0.17 |
-0.46 |
-0.24 |
-0.21 |
-0.2 |
-0.18 |
-0.25 |
-0.4 |
| EPS |
-0.92 |
0.0596 |
-0.84 |
-1.82 |
-1.18 |
-0.96 |
-1.85 |
-0.87 |
-1.05 |
-1.28 |
| EPS Diluted |
-0.92 |
0.059 |
-0.84 |
-1.82 |
-1.18 |
-0.96 |
-1.85 |
-0.87 |
-1.05 |
-1.28 |
| Weighted Average Shares
Out |
$22.68 M
|
$20.70 M
|
$19.27 M
|
$18.06 M
|
$14.62 M
|
$12.57 M
|
$4.82 M
|
$7.51 M
|
$7.51 M
|
$7.44 M
|
| Weighted Average Shares
Out Diluted |
$22.68 M
|
$20.95 M
|
$19.27 M
|
$18.06 M
|
$14.62 M
|
$12.57 M
|
$4.82 M
|
$7.51 M
|
$7.51 M
|
$7.44 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
